How much revenue does Mektovi (binimetinib + something else) generate?
I don’t have any provided financial dataset or cited sources here that report Mektovi’s revenue (global or by country/quarter). To answer with accuracy, I’d need at least one of the following: company-reported revenue figures, a specific analyst/market-research source, or a timeframe (e.g., “2023 revenue” or “last 12 months”).
Which year’s Mektovi revenue are you looking for?
Revenue figures change a lot by year and by the period you mean (annual vs. quarterly vs. trailing twelve months). If you tell me the year (and currency/region), I can structure the answer around that exact period—but I still need the underlying source numbers to cite.
Is “Mektovi revenue” from sales, royalties, or total company revenue?
“Mektovi revenue” can refer to different concepts:
- net sales for the drug (gross sales minus returns, rebates, etc.)
- revenue recognized under accounting rules (can differ from sales timing)
- royalties or collaboration revenue tied to the drug
- total revenue of the company that sells Mektovi (much broader than drug-only revenue)
If you confirm which one you mean, I can narrow the definition.
What product context might be causing confusion?
“Mektovi” is often used in searching alongside other drug names and bundled therapies. If you meant a different spelling or a different product line, revenue estimates can differ. If you share the indication or the exact product name as listed by the source you’re using, I can align it.
What I need from you to give a precise answer
Reply with:
1) the year or timeframe (e.g., 2023, 2024 Q1, trailing 12 months)
2) whether you want global or a specific country/region
3) whether you mean net sales (drug revenue) vs. company revenue
4) any source you’re working from (link or pasted figures)
Once you provide that, I can produce a clean, cited revenue answer.